2667 related articles for article (PubMed ID: 7910054)
1. Taxol (paclitaxel): a novel anti-microtubule agent with remarkable anti-neoplastic activity.
Foa R; Norton L; Seidman AD
Int J Clin Lab Res; 1994; 24(1):6-14. PubMed ID: 7910054
[TBL] [Abstract][Full Text] [Related]
2. [Paclitaxel (Taxol) and docetaxel (Taxotere): results of phase II trials in monochemotherapy].
Fumoleau P; Perrocheau G; Maugard-Louboutin C; Lemevel B
Bull Cancer; 1995 Aug; 82(8):629-36. PubMed ID: 7492819
[TBL] [Abstract][Full Text] [Related]
3. [Taxoids: structural and experimental properties].
Lavelle F; Combeau C; Commerçon A
Bull Cancer; 1995 Apr; 82(4):249-64. PubMed ID: 10846536
[TBL] [Abstract][Full Text] [Related]
4. Taxanes: a new class of antitumor agents.
Huizing MT; Misser VH; Pieters RC; ten Bokkel Huinink WW; Veenhof CH; Vermorken JB; Pinedo HM; Beijnen JH
Cancer Invest; 1995; 13(4):381-404. PubMed ID: 7627725
[TBL] [Abstract][Full Text] [Related]
5. Docetaxel: a review of its pharmacology and clinical activity.
Trudeau ME
Can J Oncol; 1996 Jun; 6(1):443-57. PubMed ID: 8853517
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel (Taxol) and docetaxel (Taxotere): active chemotherapeutic agents in lung cancer.
Francis PA; Kris MG; Rigas JR; Grant SC; Miller VA
Lung Cancer; 1995 Apr; 12 Suppl 1():S163-72. PubMed ID: 7551925
[TBL] [Abstract][Full Text] [Related]
7. Taxol in ovarian cancer.
Runowicz CD; Wiernik PH; Einzig AI; Goldberg GL; Horwitz SB
Cancer; 1993 Feb; 71(4 Suppl):1591-6. PubMed ID: 8094322
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel (Taxol) and docetaxel (Taxotere): not simply two of a kind.
Verweij J; Clavel M; Chevalier B
Ann Oncol; 1994 Jul; 5(6):495-505. PubMed ID: 7918121
[TBL] [Abstract][Full Text] [Related]
9. New microtubular agents in pediatric oncology.
Seibel NL; Reaman GH
Invest New Drugs; 1996; 14(1):49-54. PubMed ID: 8880393
[TBL] [Abstract][Full Text] [Related]
10. [Taxotere: from yew's needles to clinical practice].
Lavelle F; Gueritte-Voegelein F; Guenard D
Bull Cancer; 1993 Apr; 80(4):326-38. PubMed ID: 7909695
[TBL] [Abstract][Full Text] [Related]
11. The taxoids: paclitaxel (Taxol) and docetaxel (Taxotere).
Pazdur R; Kudelka AP; Kavanagh JJ; Cohen PR; Raber MN
Cancer Treat Rev; 1993 Oct; 19(4):351-86. PubMed ID: 8106152
[TBL] [Abstract][Full Text] [Related]
12. [Paclitaxel (taxol): a review of its antitumor activity and toxicity in clinical studies].
Yamazaki S; Sekine I; Saijo N
Gan To Kagaku Ryoho; 1998 Mar; 25(4):605-15. PubMed ID: 9530372
[TBL] [Abstract][Full Text] [Related]
13. Clinical toxicities encountered with paclitaxel (Taxol).
Rowinsky EK; Eisenhauer EA; Chaudhry V; Arbuck SG; Donehower RC
Semin Oncol; 1993 Aug; 20(4 Suppl 3):1-15. PubMed ID: 8102012
[TBL] [Abstract][Full Text] [Related]
14. The taxoids. Comparative clinical pharmacology and therapeutic potential.
Eisenhauer EA; Vermorken JB
Drugs; 1998 Jan; 55(1):5-30. PubMed ID: 9463787
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacological action of paclitaxel].
Potemski P; Płuzańska A
Pol Merkur Lekarski; 1999 Jan; 6(31):27-9. PubMed ID: 10344150
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel (Taxol): a review of its antitumor activity in clinical studies Minireview.
Hájek R; Vorlicek J; Slavik M
Neoplasma; 1996; 43(3):141-54. PubMed ID: 8841500
[TBL] [Abstract][Full Text] [Related]
17. Risks and benefits of taxanes in breast and ovarian cancer.
Michaud LB; Valero V; Hortobagyi G
Drug Saf; 2000 Nov; 23(5):401-28. PubMed ID: 11085347
[TBL] [Abstract][Full Text] [Related]
18. The scientific rationale for developing taxoids.
Aapro M
Anticancer Drugs; 1996 Aug; 7 Suppl 2():33-6. PubMed ID: 8862709
[TBL] [Abstract][Full Text] [Related]
19. [Development of a new tubulin-interacting agent, docetaxel (taxotere) in Japan].
Tsukagoshi S
Gan To Kagaku Ryoho; 1997 Jul; 24(9):1167-74. PubMed ID: 9239173
[TBL] [Abstract][Full Text] [Related]
20. The taxoids: paclitaxel and docetaxel.
Gelmon K
Lancet; 1994 Nov; 344(8932):1267-72. PubMed ID: 7967989
[No Abstract] [Full Text] [Related]
[Next] [New Search]
